TY  - JOUR
AU  - Fabian, Johannes
AU  - Lodrini, Marco
AU  - Oehme, Ina
AU  - Schier, Marie C
AU  - Thole, Theresa
AU  - Hielscher, Thomas
AU  - Kopp-Schneider, Annette
AU  - Opitz, Lennart
AU  - Capper, David
AU  - von Deimling, Andreas
AU  - Wiegand, Inga
AU  - Milde, Till
AU  - Mahlknecht, Ulrich
AU  - Westermann, Frank
AU  - Popanda, Odilia
AU  - Roels, Frederik
AU  - Hero, Barbara
AU  - Berthold, Frank
AU  - Fischer, Matthias
AU  - Kulozik, Andreas E
AU  - Witt, Olaf
AU  - Deubzer, Hedwig E
TI  - GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
JO  - Cancer research
VL  - 74
IS  - 9
SN  - 1538-7445
CY  - Philadelphia, Pa.
PB  - AACR
M1  - DKFZ-2017-00507
SP  - 2604 - 2616
PY  - 2014
AB  - Neuroblastoma is an embryonic solid tumor of neural crest origin and accounts for 11
KW  - Antineoplastic Agents (NLM Chemicals)
KW  - GRHL1 protein, human (NLM Chemicals)
KW  - Histone Deacetylase Inhibitors (NLM Chemicals)
KW  - Hydroxamic Acids (NLM Chemicals)
KW  - Indoles (NLM Chemicals)
KW  - MYCN protein, human (NLM Chemicals)
KW  - N-Myc Proto-Oncogene Protein (NLM Chemicals)
KW  - Nuclear Proteins (NLM Chemicals)
KW  - Oncogene Proteins (NLM Chemicals)
KW  - Repressor Proteins (NLM Chemicals)
KW  - panobinostat (NLM Chemicals)
KW  - Histone Deacetylases (NLM Chemicals)
KW  - histone deacetylase 3 (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:24419085
DO  - DOI:10.1158/0008-5472.CAN-13-1904
UR  - https://inrepo02.dkfz.de/record/119916
ER  -